MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.107.707257

Медицинская библиотека · Circulation · 2007

Rad GTPase deficiency leads to cardiac hypertrophy.

Chang Lin, Zhang Jifeng, Tseng Yu-Hua, Xie Chang-Qing, Ilany Jacob, Brüning Jens C, Sun Zhongcui, Zhu Xiaojun, Cui Taixing, Youker Keith A, Yang Qinglin, Day Sharlene M, Kahn C Ronald, Chen Y Eugene

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Rad (Ras associated with diabetes) GTPase is the prototypic member of a subfamily of Ras-related small G proteins. The aim of the present study was to define whether Rad plays an important role in mediating cardiac hypertrophy.

METHODS AND

RESULTS

We document for the first time that levels of Rad mRNA and protein were decreased significantly in human failing hearts (n=10) compared with normal hearts (n=3; P<0.01). Similarly, Rad expression was decreased significantly in cardiac hypertrophy induced by pressure overload and in cultured cardiomyocytes with hypertrophy induced by 10 micromol/L phenylephrine. Gain and loss of Rad function in cardiomyocytes significantly inhibited and increased phenylephrine-induced hypertrophy, respectively. In addition, activation of calcium-calmodulin-dependent kinase II (CaMKII), a strong inducer of cardiac hypertrophy, was significantly inhibited by Rad overexpression. Conversely, downregulation of CaMKIIdelta by RNA interference technology attenuated the phenylephrine-induced hypertrophic response in cardiomyocytes in which Rad was also knocked down. To further elucidate the potential role of Rad in vivo, we generated Rad-deficient mice and demonstrated that they were more susceptible to cardiac hypertrophy associated with increased CaMKII phosphorylation than wild-type littermate controls.

CONCLUSIONS

The present data document for the first time that Rad is a novel mediator that inhibits cardiac hypertrophy through the CaMKII pathway. The present study will have significant implications for understanding the mechanisms of cardiac hypertrophy and setting the basis for the development of new strategies for treatment of cardiac hypertrophy.

Для цитирования: Chang Lin, Zhang Jifeng, Tseng Yu-Hua, Xie Chang-Qing, Ilany Jacob, Brüning Jens C, Sun Zhongcui, Zhu Xiaojun, Cui Taixing, Youker Keith A, Yang Qinglin, Day Sharlene M, Kahn C Ronald, Chen Y Eugene. Rad GTPase deficiency leads to cardiac hypertrophy.. Circulation. 2007. DOI: 10.1161/circulationaha.107.707257.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.